Status:
COMPLETED
Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan
Lead Sponsor:
University Medical Centre Ljubljana
Conditions:
Myocardial Infarction
Eligibility:
MALE
Up to 55 years
Phase:
NA
Brief Summary
The concept of improving arterial wall characteristics by treatment with a very low-dose combination of fluvastatin and valsartan (low-flu/val) in stable, post-myocardial infarction (MI) patients was ...
Eligibility Criteria
Inclusion
- history of MI in the last 0.5 to 5 years
- males
- aged under 55 years
Exclusion
- diabetes mellitus
- manifest peripheral artery disease or carotid artery disease
- acute infection
- chronic diseases
- present therapy with fluvastatin and/or valsartan.
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03309618
Start Date
November 1 2012
End Date
November 1 2014
Last Update
October 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Vascular Diseases, University Medical Centre Ljubljana
Ljubljana, Slovenia, SI-1000